PMID 32595523

Research
All papers

Oral Contraceptive Use Influences On-Kinetic Adaptations to Sprint Interval Training in Recreationally-Active Women

Question

Does oral contraceptive use influence pulmonary, cardiovascular, and muscle oxygenation adaptations to sprint interval training in recreationally active women?

Summary

Recreationally active women completed 4 weeks of supervised cycle sprint interval training. Training improved time to fatigue in both oral-contraceptive users and naturally cycling women, but physiological adaptations differed by hormonal status: VO2 kinetics improved mainly in naturally cycling women, while muscle oxygenation kinetics improved mainly in oral-contraceptive users.

Methodology

  • 47 healthy recreationally active women grouped by oral contraceptive use.
  • 47 participants.
  • Wattbike cycling.
  • Work intervals: 1 min.
  • Recovery: 2 min passive recovery.
  • Intensity: 100-120% peak power output; maximal sustainable effort.
  • About 30 min interval block.
  • 3 sessions/week.
  • 4 weeks.
  • Non-randomized comparative intervention grouped by oral contraceptive status
  • Time to fatigue, VO2 kinetics, and Muscle oxygenation were tracked.

Outcomes

Time to fatigue

Both groups improved exercise tolerance.

Time to fatigue increased in both groups, p<0.001; no clear between-group difference.

Improved

VO2 kinetics

VO2 kinetics improved in naturally cycling women but not oral-contraceptive users.

MC improved at moderate p=0.021 and high p=0.015; group x time moderate p=0.020.

Mixed

TSI kinetics

Muscle tissue saturation kinetics improved in oral-contraceptive users but not naturally cycling women.

OC improved at moderate and high intensity, both p<0.001; group x time moderate p=0.001, high p<0.001.

Mixed

Insights

  • A 1:2 work-rest cycle SIT format improved performance in active women.
  • Adaptation mechanisms may vary by oral contraceptive status.
  • Mechanistic physiology findings should not be simplified into one-size-fits-all claims.

Limitations

  • Groups were not randomized by contraceptive status.
  • Short 4-week intervention.
  • Mechanistic outcomes may not map directly to user-facing benefits.
  • Safety and adherence reporting was limited.
  • Female hormonal subgroup findings limit generalizability.

Safety

  • Training was supervised and HR/RPE/power were recorded.
  • Adverse events and injuries were not clearly reported.